Call for Papers
Molecular Pathology in Diagnosis – Focus on the Chinese Population
The Journal of Clinical Pathology invites submissions that expand the molecular pathology field, emphasizing diagnostic applications pertinent to the Chinese population. We are interested in innovative research, in-depth reviews, and illustrative case studies that apply molecular pathology within patient management in China. This issue will feature studies capturing the unique genetic makeup, environmental factors, and disease epidemiology in China. Contributions may include but are not limited to, the latest in molecular diagnostics, prognostic developments, and tailored therapeutic strategies. We are particularly interested in articles that:
- Investigate molecular biomarkers for diagnosis and prognosis.
- The role of gene fusion events in tumor diagnosis and their implications for targeted therapy.
- Evaluate novel molecular techniques for detecting and monitoring diseases.
- Discuss the integration of molecular pathology into routine clinical practice.
- Examine molecular pathology's role in the stratification of patients for targeted therapies.
- Present advancements in molecular genetics related to common diseases in China.
Please submit your manuscript before September 1, 2024 via the journal’s online submission system. All submissions will undergo thorough peer review. When submitting, please select the special issue name “Molecular Pathology in Diagnosis”. Submissions must be original and not currently submitted elsewhere. Studies should have clear clinical relevance and the potential to enhance patient care. Before submitting, please consult the Author Guidelines for more information about the journal, manuscript types, and instructions for manuscript preparation. For further information, please contact the Guest Editors. The Call for Papers is also available to view as a PDF.